Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Scleroderma Clinical Research Samples
Discovery Life Sciences provides the highest quality Scleroderma Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Scleroderma Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 19 of 19 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Current Medications | Diagnosis | ICD10 codes | CT | MRI | Ultrasound | X-ray | Complete Blood Count | ENA Panel | Additional Testing | Previous Treatment History | Comprehensive Metabolic Panel | MRI Result | CT | Ultrasound |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EDP0000-AA900032765110817DD | Scleroderma | Russia | K2 EDTA Plasma | 1.00 | 5.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 08-Nov-17 | Clinical Diagnosis | Positive for Scleroderma. Telangiectasia, Digital ischemia, Ankylosis of wrist and joints, Dyspnea, Swelling of the lower extremities, Pouch syndrome | Comprehensive Metabolic Panel | Glucose 4.7 mmol/L | BUN 13 mmol/L | Creatinine 137 umol/L | Total Protein 75 g/L | Total Bilirubin 12.8 umol/L | SGOT (AST) 22 IU/L | SGPT (ALT) 20 IU/L | 24-Oct-17 | Lipid Panel | Cholesterol 7.3 mmol/L | 24-Oct-17 | $150.00 | Unknown | Cardiac ischemia; Chronic gastritis | Methylprednisolone 4 mg/day | Isosorbide 40 mg/day | Bisoprolol 5 mg/day | Warfarin 2.5 mg/day | Amlodipine 5 mg/day | Furosemide 20 mg/day | Scleroderma | M34.0 | CT - Fibrosing alveolitis 3-Nov-2017 | Ultrasound - Cyst of the right kidney 7-Nov-2017 | WBC 9.0 x 10^9/L|RBC 5.1 x 10^12/L|Hemoglobin 152 g/L|Neutrophils 69%|Lymphocytes 26%|Monocytes 4%| Eosinophils 1% 24-Oct-17 | Sci-70 +++(3) IU/mL | 26-May-16 | ANA 1:320 IU/mL | CRP 23.4mg/L | 3-Nov-17 | Methylprednisolone 4 mg/day since 2002 | Cyclophosphamide 1000 mg once/month May-2016 Dec-2016 | ||||||
| EDP0000-AA900032768011818DD | Scleroderma | Russia | K2 EDTA Plasma | 1.00 | 8.00 | $150.00 | 21 Y | Male | Non-Hispanic | <-70C | 18-Jan-18 | Clinical Diagnosis | Systemic Scleroderma | Date of Diagnosis | 4-Sep-17 | Organ Involvement | Pneumofibrosis | $150.00 | Unknown | Chronic gastritis | Methotrexate 15 mg 1/week | Methylprednisolone 12 mg/day | Omeprazole 20 mg/day | Scleroderma | M34.0 | WBC 8.7 x 10^9/L | RBC 3.4 x 10^12/L | Hemoglobin 127 g/L | Neutrophils 62% | Lymphocytes 29% | Monocytes 5% | Eosinophils 4% | 17-Jan-18 | Sci-70 ++(2) iu/ml 17-Jan-18 | ANA >1:640 iu/ml | CRP 10.4mg/L 17-Jan-18 | Glucose 5.1 mmol/L | BUN 4.9 mmol/L | Creatinine 78 umol/L | Sodium 140 mmol/L | Potassiium 4.8 mmol/L | Total Protein 72 g/L | SGOT (AST) 21 iu/L | SGPT (ALT) 16 iu/L 17-Jan-18 | Pneumofibrosis 18-Jan-18 | ||||||||
| EDP0000-AA900069256110717DD | Scleroderma | Russia | K2 EDTA Plasma | 1.00 | 1.00 | $150.00 | 21 Y | Female | Non-Hispanic | <-70C | 07-Nov-17 | Clinical Diagnosis | Positive for Scleroderma. Raynaud's Syndrome, Hyperpigmentation, Calcinosis | Comprehensive Metabolic Panel | Glucose 5.6 mmol/L | BUN 4.06 mmol/L | Creatinine 82 umol/L | EGFR 88 ml/min | Total Bilirubin 8.6 umol/L | SGOT (AST) 15 IU/L | SGPT (ALT) 17 IU/L | | 17-Oct-17 | Lipid Panel | Cholesterol 5.2 mmol/L | 17-Oct-17 | $150.00 | Unknown | Chronic gastritis; Reflux esophagitis | Prednisolone 2.5 mg/day | Omeprazole 20 mg/day | Rituximab 1000 mg 1/every 6 months | Scleroderma | M34.0 | X-ray - Chest Normal 10-Oct-2017 | WBC 5.2 x 10^9/L| RBC 4.26 x 10^12/L| Hemoglobin 106 g/L|Hematocrit 34.6%|MCV 81.1 fL|MCH 25 pg|| MCHC 308 g/L|RDW 10.8%|Neutrophils 57.3%|Lymphocytes 32.8%|Monocytes 8.9%| Eosinophils 0.2%|Basophils 0.7% 17-Oct-17 | Anti-RNP NEG | Anti-Sm NEG | Anti-SS-A NEG | Anti-SS-B NEG | Scl-70 +++++(5) IU/mL | Anti-Jo-1 NEG | 2-Sep-17 | ANA 1:2560 IU/mL | ESR 12 mm/hr | CRP 2.4 mg/L | RF 16 IU/mL | 2-Sep-17 | Methotrexate 20 mg/week 10-Oct-2011 - 20-Oct-2014 | Prednisolone 30 mg/day since 30-Sep-2007 | Cyclosporine 125 mg/day 30-Sep-2007 - 10-May-2009 | ||||||
| EDP0000-AA900074262101817DD | Scleroderma | Russia | K2 EDTA Plasma | 1.00 | 8.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 18-Oct-17 | Clinical Diagnosis | Positive for Scleroderma. Raynaud's Syndrome, Fever, Arthritis in knees and hands | Comprehensive Metabolic Panel | Glucose 4.97 mmol/L|BUN 3.6 mmol/L|Creatinine 78 umol/L|EGFR 90 ml/min|Sodium 142 mmol/L |Potassium 3.3 mmol/L|Chloride 107 mmol/L|Calcium 1.23 mmol/L|Total Protein 76 g/L| Total Bilirubin 9.8 umol/L|SGOT (AST) 13 IU/L|SGPT (ALT) 18 IU/L | 12-Oct-17 | Lipid Panel | Cholesterol 6.2 mmol/L | 12-Oct-17 | $150.00 | Unknown | Chronic gastroduodenitis; Autoimmune thyroiditis; Arterial hypertension | Methylprednisolone 16 mg/day | L-thyroxine 75 mcg/day | Nifedipine 20 mg/day | Captopril 50 mg/day | Scleroderma | M34.0 | CT - Normal 5-Sep-2017 | Ultrasound - Heart Normal 10-Sep-2017 | WBC 5.74 x 10^9/L|RBC 3.66 x 10^12/L|Hemoglobin 10.9 g/dL|Hematocrit 31.9%|MCV 87.2 fL| MCH 29.8 pg|MCHC 34.2 g/dL|RDW 12.1%|Neutrophils 42.4%|Lymphocytes 47%|Monocytes 8.5%| Eosinophils 1.2%|Basophils 0.9% 12-Oct-17 | Anti-RNP NEG | Anti-Sm NEG | Anti-SS-A NEG | Anti-SS-B NEG | Scl-70 ++(2) IU/mL | Anti-Jo-1 NEG | 12-Oct-17 | ANA 1:1280 IU/mL | ESR 17 mm/hr | CRP 1.7 mg/L | RF 6.3 IU/mL | Anti-dsDNA 15 IU/mL | C-3 1.36 g/L | 12-Oct-17 | None | ||||||
| EDP0000-AA900081540020618DD | Scleroderma | Russia | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 06-Feb-18 | Clinical Diagnosis | Systemic Scleroderma | Date of Diagnosis | 1-Jan-13 | Organ Involvement | None | $150.00 | Unknown | Chronic gastroduodenitis | Methylprednisolone 4 mg/day | Cuprenil 250 mg 2/day | Omeprazole 20 mg 2/day | Scleroderma | M34.0 | WBC 4.3 x 10^9/L | RBC 3.9 x 10^12/L | Hemoglobin 112 g/L | Hematocrit 36.1% | MCV 92 fL | MCH 28.5 pg | MCHC 312 g/L | RDW 13.2% | Neutrophils 52.7% | Lymphocytes 9.2% | Monocytes 9.4% | Eosinophils 2.2% | Basophils 0.8% | 6-Feb-18 | Anti-RNP NEG | Anti-Sm NEG | Anti-SS-A NEG | Anti-SS-B NEG | Scl-70 >>100 iu/ml | Anti-Jo-1 NEG 6-Feb-18 | ANA 1:160 iu/ml | ESR 28 mm/hr | CRP 10 mg/L | RF <16 iu/ml | 6-Feb-18 | Glucose 4.6 mmol/L | Creatinine 96 umol/L | Total Protein 65 g/L | Albumin 40 g/L | Total Bilirubin 13.5 umol/L | Alkaline Phosphate 95 iu/L | SGOT (AST) 14 iu/L | SGPT (ALT) 13 iu/L 6-Feb-18 | Normal | Diffuse Changes in Liver 6-Feb-18 | ||||||||
| EDP0000-AA900081550101217DD | Scleroderma | Russia | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 53 Y | Female | Non-Hispanic | <-70C | 12-Oct-17 | Clinical Diagnosis | Positive for Scleroderma. Raynaud's Syndrome, Fever, Hair loss, Arthritis in feet and hands, Swelling of legs | Comprehensive Metabolic Panel | Glucose 4.1 mmol/L | BUN 3.1 mmol/L | Creatinine 75 umol/L | EGFR 79 ml/min | Total Bilirubin 7.5 umol/L | SGOT (AST) 11 IU/L | SGPT (ALT) 9 IU/L | 10-Oct-17 | Lipid Panel | Cholesterol 5.9 mmol/L | 10-Oct-17 | $150.00 | Unknown | Chronic gastritis | Methylprednisolone 10 g/day | Azathioprine 100 mg/day | Rituximab 1000 mg 1/every 4 weeks since 27-Jul-2017 | Omeprazole 200 mg/day | Calcium + Vitamin D 1000 mg + 400 IU per day | Scleroderma | M34.0 | CT - Interstitial fibrosis 20-Jun-2017 | Ultrasound - Heart - pulmonary hypertesion 25-Jun-2017 | WBC 7.0 x 10^9/L|RBC 4.3 x 10^12/L|Hemoglobin 144 g/L|Hematocrit 42.1%|MCV 33.3 fL| MCH 97.5 pg|MCHC 342 g/L|RDW 16.4%|Neutrophils 71.0%|Lymphocytes 15.5%|Monocytes 11.4%| Eosinophils 1.5%|Basophils 0.2% 10-Oct-17 | Anti-RNP 5.25 IU/mL Anti-Sm 4.77 IU/mL | Anti-SS-A 3.75 IU/mL Anti-SS-B 3.7 IU/mL | Scl-70 >>100 IU/mL Anti-Jo-1 4.2 IU/mL | 10-Oct-17 | ANA 1:640 IU/mL | ESR 6 mm/hr | RF 1.3 IU/mL | C-3 1.02 g/L | 10-Oct-17 | Hydroxychloroquine 400 mg/day 10-May-2016 - 20-Aug-2016 | Methylprednisolone 10 g/day since 10-May-2016 | Azathioprine 100 mg/day Since 20-Aug-2016 | Rituximab 1000 mg 1/every 4 weeks 10-Apr-2017 - 13-Jul-2017 ; 1000 mg 1/every 2 weeks 13-Jul-2017 - 27-Jul-2017 | ||||||
| EDP0000-AI900360667122219DD | Scleroderma | United States | K2 EDTA Plasma | 1.50 | 1.00 | $75.00 | 64 Y | Female | Non-Hispanic | <-70C | 22-Dec-19 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| EDP0000-AI900360691121619DD | Scleroderma | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 11 Y | Female | Non-Hispanic | <-70C | 16-Dec-19 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| EDP0000-AI900361236011020DD | Scleroderma | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 73 Y | Female | Non-Hispanic | <-70C | 10-Jan-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| EDP0000-AI900380198030120DD | Scleroderma | United States | K2 EDTA Plasma | 1.30 | 1.00 | $75.00 | 68 Y | Female | Non-Hispanic | <-70C | 01-Mar-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| EDP0000-AI900380199022820DD | Scleroderma | United States | K2 EDTA Plasma | 1.30 | 1.00 | $75.00 | 68 Y | Female | Non-Hispanic | <-70C | 28-Feb-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| EDP0000-AI900380200030920DD | Scleroderma | United States | K2 EDTA Plasma | 1.40 | 1.00 | $75.00 | 64 Y | Female | Non-Hispanic | <-70C | 09-Mar-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| EDP0000-AI900380201022620DD | Scleroderma | United States | K2 EDTA Plasma | 1.50 | 1.00 | $75.00 | 68 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| LHP0000-AI900370151111719DD | Scleroderma | United States | L. Heparin Plasma | 1.40 | 1.00 | $75.00 | 64 Y | Female | Non-Hispanic | <-70C | 17-Nov-19 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| LHP0000-AI900370639101119DD | Scleroderma | United States | L. Heparin Plasma | 1.30 | 1.00 | $75.00 | 30 Y | Female | Non-Hispanic | <-70C | 11-Oct-19 | Scleroderma | $75.00 | Unknown | Scleroderma | |||||||||||||||||||||
| LHP0000-AI900371938012920DD | Scleroderma | United States | L. Heparin Plasma | 2.00 | 1.00 | $75.00 | 66 Y | Female | Non-Hispanic | <-70C | 29-Jan-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| LHP0000-AI900372827012420DD | Scleroderma | United States | L. Heparin Plasma | 1.30 | 1.00 | $75.00 | 86 Y | Male | Non-Hispanic | <-70C | 24-Jan-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| LHP0000-AI900372828012520DD | Scleroderma | United States | L. Heparin Plasma | 1.30 | 1.00 | $75.00 | 86 Y | Male | Non-Hispanic | <-70C | 25-Jan-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma | ||||||||||||||||||||
| LHP0000-AI900380196022920DD | Scleroderma | United States | L. Heparin Plasma | 2.50 | 1.00 | $75.00 | 66 Y | Female | Non-Hispanic | <-70C | 29-Feb-20 | Diagnosis | Scleroderma | $75.00 | Unknown | Scleroderma |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.